Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDMC in Peripheral Neuropathic Pain
NCT04480164Phase 2Suspended
- Start
- Jun 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of n-desmethylclobazam in Peripheral neuropathic pain. Started Jun 2020; status: suspended.
02
Drugs
n-desmethylclobazam
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT04480164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04480164.